PERSONAL INFORMATION
Name: LI Bosheng
Gender: Male
Title: Associate Research Fellow
Position: Teacher
CONTACT INFORMATION
Email: boshengli@cqmu.edu.cn
Address: No.1, Medical College Road, Yuzhong District, Chongqing
Phone: +86-15902310360
EDUCATION EXPERIENCE
2019.09-2022.06 PhD, Biochemistry and molecular biology, Army Medical University.
2010.09-2013.06 Master's degree, Microbiology and Biochemical Pharmacy, Army Medical University.
2004.09-2008.06 Bachelor, Medical Experimental Technology, Army Medical University.
WORKING EXPERIENCE
2022.09-present Associate Research Fellow, Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University.
2020.12-2022.07 Associate Research Fellow, Department of Xinqiao Hospital, Army Medical University.
2015.12-2020.11 Assistant Research Fellow, Department of Xinqiao Hospital, Army Medical University.
2014.07-2015.11, Probationer, Department of Xinqiao Hospital, Army Medical University.
2008.07-2014.06, Probationer, Department of Pharmacy, Army Medical University.
RESEARCH INTERESTS
LI Bosheng, Associate Research Fellow, and Master's Supervisor. He is a member of the Communist Party of China. He is a specially-appointed Associate Professor at the Basic Medical School of Chongqing Medical University. He is a member of the China Biochemistry and Molecular Biology Association and a committee member of the Youth Committee of Digestive Disease Specialization under the Chongqing Medical Association. He presides over two general projects funded by the National Natural Science Foundation, one youth fund project by the National Natural Science Foundation, and three general projects funded by the Chongqing Natural Science Foundation. He has published 7 SCI papers in Oncogene, Cancer Letters, Clinical and Translational Medicine, etc, as the first or corresponding author. His primary research direction is tumor metabolism and epigenetic regulation.
PUBLICATIONS (Five representative works)
1. Li B, Kang H, Xiao Y, Du Y, Xiao Y, Song G, Zhang Y, Guo Y, Yang F, He F, Yang S. LncRNA GAL promotes colorectal cancer liver metastasis through stabilizing GLUT1. Oncogene. 2022 Mar;41(13):1882-1894.
2. Li BS, Zuo QF, Zhao YL, Xiao B, Zhuang Y, Mao XH, Wu C, Yang SM, Zeng H, Zou QM, Guo G. MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival. Oncogene. 2015 May 14;34(20):2556-65.
3. Xiao YF, Li BS, Liu JJ, Wang SM, Liu J, Yang H, Hu YY, Gong CL, Li JL, Yang SM. Role of lncSLCO1C1 in gastric cancer progression and resistance to oxaliplatin therapy. Clin Transl Med. 2022 Apr;12(4):e691.
4. Wu Y, Hao N, Wang S, Yang X, Xiao Y, Yang H, Yang S, Li B. Long Noncoding RNA Lnc-TLN2-4:1 Suppresses Gastric Cancer Metastasis and Is Associated with Patient Survival. J Oncol. 2020 Mar 11;2020:8681361.
5. Ma DH, Li BS, Liu JJ, Xiao YF, Yong X, Wang SM, Wu YY, Zhu HB, Wang DX, Yang SM. miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway. Cancer Lett. 2017 Nov 1;408:23-32.
